Year-End Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1082, Food and Drug Administration Revitalization Act of 2007 (Importation, Follow-On Biologics, Patent settlements, Drug Safety or PDUFA). HR 2900, Food and Drug Administration Amendments Act of 2007 (Drug Safety & PDUFA).

LobbyistCovered position, as disclosed
JOHN HOLSCLAW N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2900 (110th), S. 1082 (110th)

Medicare/Medicaid MMM

HR 4 Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit. S. 3 Medicare Prescription Drug Price Negotiation Act of 2007, Part D Benefit

LobbyistCovered position, as disclosed
JOHN HOLSCLAW N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4 (110th), S. 3 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S. 316, Preserve Access to Affordable Generics Act, patent settlements International Intellecutal Property Issues

LobbyistCovered position, as disclosed
JOHN HOLSCLAW N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th), S. 316 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.